Bart Scott is an Oncology physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Washington Medical Ctr
1959 NE Pacific St
Seattle, WA 981950001
Telephone
206-288-1000Registry record last updated 20 Nov 2012.
Clinical trials
- JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Sponsor: Jasper Therapeutics, Inc.
- Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Sponsor: Fred Hutchinson Cancer Center
- Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202554 payments$61,631openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202552 payments$51,559openpaymentsdata.cms.gov ↗
- Geron CorporationProgram year202527 payments$36,010openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Improving Allogenic Transplant Outcomes in Myeloid Malignancies
Fred Hutchinson Cancer Research Center
FY2011$136,485K23HL084054 - Improving Allogenic Transplant Outcomes in Myeloid Malignancies
Fred Hutchinson Cancer Research Center
FY2010$136,485K23HL084054 - Improving Allogenic Transplant Outcomes in Myeloid Malignancies
Fred Hutchinson Cancer Research Center
FY2009$136,485K23HL084054
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”